Fig. 3: Passive transfer of immune serum can protect from lethal RVFV.
From: Immune correlates of protection following Rift Valley fever virus vaccination

Naïve mice (n = 3–5 per experimental group) were inoculated with 200 uL of serum from vaccinated mice, either undiluted or diluted 1:5, 1:10, 1:20, 1:100, or 1:500. Control mice were inoculated with normal mouse serum. All mice were bled then challenged with WT RVFV. A Endpoint titers of RVFV-specific antibodies were determined via ELISA (B) and FRNT (C) 1 day prior to challenge. Mice were then challenged with 2 or 200 TCID50 of WT RVFV and monitored for survival (D). Terminal viral RNA load (E) and ELISA titer (F) were also measured. Open circles in E&F represent animals that died or required euthanasia while closed circles represent animals that survived; the dotted line is the LOD of the assay. For ELISA and FRNT80 graphs the dotted line is the LOD (100 for ELISA, 40 for FRNT80). Negative values were plotted at 50 and 20, respectively. Geometric means and geometric standard deviation are noted.